2023年10月2日 · To fulfil these aims, we formed the UK Biobank Pharma Proteomics Project (UKB-PPP)—a precompetitive consortium of 13 biopharmaceutical companies funding the …

The UKB-PPP is a collaboration between the UK Biobank (UKB) and thirteen biopharmaceutical companies characterising the plasma proteomic profiles of 54,219 UKB participants.

'UKB-PPP' (Synapse ID: syn51364943) is a project on Synapse. Synapse is a platform for supporting scientific collaborations centered around shared biomedical data sets.

As recently announced, the UK Biobank Pharma Proteomics Project (UKB-PPP) aims to use Olink® Explore HT to measure over 5,400 proteins in 600,000 samples from UKB participants.

2023年10月4日 · The UKB Pharma Plasma Proteome (UKB-PPP) cohort comprises plasma samples from 54,219 individuals, including 46,595 randomly selected participants, 6,376 …

'UKB-PPP pGWAS summary statistics' (Synapse ID: syn51365301) is a folder on Synapse. Synapse is a platform for supporting scientific collaborations centered around shared …

Large-scale proteomic profiling to facilitate genetics-guided drug discovery and precision medicine: The UK Biobank - Pharma Proteomics Project (UKB-PPP)

Biobank Pharma Proteomics Project (UKB-PPP) for normalized protein expression (.NPX) data generated using the antibody-based Olink Explore™ Proximity Extension Assay (PEA) in …

2024年8月2日 · The UKB-PPP’s open-access resource paves the way for future studies, enabling scientists to explore the biological mechanisms underlying proteo-genomic discoveries. …

2025年1月9日 · WALTHAM, Mass.-- (BUSINESS WIRE)-- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the UK Biobank Pharma …